搜索临床试验以:Interleukin-2 Receptor
总计61018个结果
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)终止转移性黑色素瘤 | IV 期皮肤黑色素瘤 | IIIB 期皮肤黑色素瘤 | IIIC 期皮肤黑色素瘤 | IIIA 期皮肤黑色素瘤 | 头颈部 III 期粘膜黑色素瘤 | 头颈部IVA期粘膜黑色素瘤 | 头颈部 IVB 期粘膜黑色素瘤 | 头颈部 IVC 期粘膜黑色素瘤美国
-
Blumenthal Cancer Center at Carolinas Medical Center未知
-
Sahlgrenska University Hospital, Sweden尚未招聘胰腺癌 | 手术 | 转移 | 免疫抑制
-
Maxim Pharmaceuticals完全的
-
Roger Williams Medical CenterNational Cancer Institute (NCI); Beth Israel Deaconess Medical Center完全的
-
Georgetown UniversityNational Cancer Institute (NCI)完全的
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的
-
European Organisation for Research and Treatment...完全的
-
University of DebrecenUniversity of Pecs; National Institute of Oncology, Hungary; Uzsoki Street Hospital, Hungary招聘中
-
M.D. Anderson Cancer CenterKSQ Therapeutics, Inc.招聘中
-
Johns Hopkins All Children's HospitalCannonball Kids' Cancer Foundation; Swim Across America Foundation; Benjamin Gilkey Fund尚未招聘
-
University of Southern CaliforniaNational Cancer Institute (NCI)尚未招聘
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Zhejiang UniversityZcapsule Pharmaceuticals (Shaoxing) Co., Ltd招聘中
-
Centre Hospitalier St AnneFor Drug Consulting招聘中
-
Erasmus Medical CenterLudwig Institute for Cancer Research; Dutch Cancer Society; Stichting Coolsingel Rotterdam grant; Jan Ivo Stichting grant招聘中
-
H. Lee Moffitt Cancer Center and Research InstituteClinigen, Inc.招聘中
-
H. Lee Moffitt Cancer Center and Research Institute主动,不招人
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Iovance Biotherapeutics, Inc.; The V Foundation for Cancer Research完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Iovance Biotherapeutics, Inc.主动,不招人恶性实体肿瘤 | 软组织肉瘤 | 复发性卵巢癌 | 三阴性乳腺癌 | 复发性骨肉瘤 | 难治性骨肉瘤 | 骨肉瘤 | 骨巨细胞瘤 | 卵巢癌肉瘤 | 铂类耐药卵巢癌 | 去分化软骨肉瘤 | 骨巨细胞瘤的恶性程度 | 低分化甲状腺癌 | 甲状腺间变性癌 | 甲状腺鳞状细胞癌 | 未分化高级别多形性骨肉瘤美国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人转移性黑色素瘤 | III 期皮肤黑色素瘤 AJCC v7 | IV 期皮肤黑色素瘤 AJCC v6 和 v7 | IIIC 期皮肤黑色素瘤 AJCC v7 | IIIA 期皮肤黑色素瘤 AJCC v7 | IIIB 期皮肤黑色素瘤 AJCC v7美国
-
National Cancer Institute (NCI)主动,不招人
-
University Health Network, Toronto主动,不招人
-
Roswell Park Cancer Institute主动,不招人复发性输卵管癌 | 复发性卵巢癌 | 复发性原发性腹膜癌 | 铂类耐药输卵管癌 | 铂类耐药原发性腹膜癌 | 铂类耐药卵巢癌 | 铂敏感性卵巢癌 | 难治性卵巢癌 | 铂敏感性输卵管癌 | 铂敏感原发性腹膜癌 | 难治性输卵管癌 | 难治性原发性腹膜癌美国
-
National Cancer Institute (NCI)完全的
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Iovance Biotherapeutics, Inc.主动,不招人
-
Centre Hospitalier Universitaire Vaudois主动,不招人
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of Medicine主动,不招人
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Prometheus Laboratories; Miltenyi Biomedicine GmbH主动,不招人
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
Washington University School of MedicineNational Cancer Institute (NCI); American Society of Clinical Oncology; ImmunityBio, Inc.; The Leukemia... 和其他合作者终止
-
The Netherlands Cancer InstituteCopenhagen University Hospital at Herlev主动,不招人
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的急性髓性白血病 | 既往骨髓增生异常综合征引起的急性髓性白血病 | 慢性粒单核细胞白血病 | 急性红系白血病 | 急性巨核细胞白血病 | 骨髓增生异常综合症 | 高危骨髓增生异常综合征 | 母细胞期慢性粒细胞白血病,BCR-ABL1 阳性 | 复发性慢性粒细胞白血病,BCR-ABL1 阳性 | 治疗相关的急性髓性白血病 | 治疗相关性骨髓增生异常综合征 | 缓解期急性髓性白血病 | 加速期慢性粒细胞白血病,BCR-ABL1 阳性 | 原始细胞低于 20% 的骨髓有核细胞 | 原始细胞低于 20% 的外周血白细胞美国
-
University of WashingtonMerck Sharp & Dohme LLC; Prometheus Laboratories终止
-
Alexandria UniversityScience and Technology Development Fund (STDF), ,Egypt完全的